Skip to content

True Terpenes Science Board

Lorem ipsum dolor sit amet, consectetur adipiscing elitorbi purus.

Lorem ipsum dolor sit amet, consectetur adipiscing elitorbi purus.

Science-based research is the surest way to propel our industry forward. We're working across industry and academia to advance the scientific understanding of terpenes and cannabis, for the benefit of the consumer and the industry.

plant-2

Dr. Ethan Russo

Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.

plant-3

Dr. Randall Murphy

Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.

plant-4

Jeremy Plumb

Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.

Explore Related Resources

Explore recent and groundbreaking contributions by our Science Board Members

1 / 3
The Nose Knows

The Nose Knows

Aroma-Not THC-Drives the Consumer Experience. A New Study Has the Evidence to Prove It.

Learn more
True Terpenes' Science Advisory Board Chair publishes findings on novel extraction technique

True Terpenes' Science Advisory Board Chair publishes findings on novel extraction technique

True Terpenes is pleased to share new research on a practical, solventless method for cannabis extraction, as part of its continuing effort to introduce advanced, innovative techniques to the terpene industry.

Learn more
Taming THC

Taming THC

Lorem ipsum dolor sit amet, consectetur adipiscing elitorbi purus nunc. Lorem ipsum dolor sit amet, consectetur adipiscing elitorbi purus nunc. Lorem ipsum dolor sit amet, consectetur adipiscing elitorbi purus nunc.

Learn more

Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and author. He is the Founder and CEO of credo-science.com.

Previously, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague, Czech Republic. Medical Director of PHYTECS (2015-2017), a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system, and from 2003-2014, he served as Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy.

Dr. Randall Murphy is a former tenured faculty member at New York University who has worked on clinical trials for pharma companies and has launched multiple pharma startups. He also designed laboratories and the widely used standards and practices in place in the U.S. National Bureau of Standards and Center for Analytical Chemistry, and the Staff Research Fellow Laboratory of Biophysical Chemistry.

Title goes here

next previous
Your Cart
My cart
Only $100.00 away from free shipping to US
Your cart is empty.

Looks like you haven't made a choice yet.